Siren Biotechnology is a pioneering company based in San Francisco, CA, that is revolutionizing cancer treatment through the integration of AAV gene therapy and cytokine immunotherapy. Their groundbreaking approach aims to overcome the limitations of past therapies and establish AAV immuno-gene therapy as the cornerstone treatment for solid tumors, starting with brain and eye cancers.
With a team of dedicated experts and a strong focus on scientific innovation, Siren Biotechnology is committed to tackling the challenges of cancer head-on. Their cutting-edge research and passion for improving patient outcomes make them a formidable force in the fight against cancer.
Generated from the website